Whereas the preponderance of the evidence suggests that SIRT1 in many contexts promotes cancer metabolism by working in conjunction with HIF and MYC family proteins, SIRT3, SIRT4 and SIRT6 all inhibit distinct aspects of the metabolic alterations observed in tumor cells. Here, MYC is linked to neoplasm.